【结 构 式】 |
【分子编号】60848 【品名】3-cyano-4-hydroxybenzohydrazide 【CA登记号】 |
【 分 子 式 】C8H7N3O2 【 分 子 量 】177.1626 【元素组成】C 54.24% H 3.98% N 23.72% O 18.06% |
合成路线1
该中间体在本合成路线中的序号:(IV)Alkylation of the sodium salt of indole-4-carbaldehyde (I) with 2,3,5,6-tetramethylbenzyl chloride (II) affords the N-alkylated indole aldehyde (III). Subsequent condensation of aldehyde (III) with 3-cyano-4-hydroxybenzoic acid hydrazide (IV) in DMSO in the presence of an acidic catalyst yields the target acyl hydrazone.
【1】 Madsen, P.; Ling, A.; Plewe, M.; et al.; Optimization of alkylidene hydrazide based human glucagon receptor antagonists. Discovery of the highly potent orally available 3-cyano-4-hydroxybenzoic acid [1-(2,3,5,6-tetramethylbenzyl)-1H-indol-4-ylmethylene]hydrazide. J Med Chem 2002, 45, 26, 5755. |
【2】 Lau, J.; Madsen, P.; Truesdale, L.K.; Sams, C.; Feng, J.; Kiel, D.; Ling, A.; Kukl, A.; Shi, S.; Plewe, M.B.; May, J. (Agouron Pharmaceuticals, Inc.; Novo Nordisk A/S); Glucagon antagonists/inverse agonists. JP 2002533439; WO 0039088 . |
合成路线2
该中间体在本合成路线中的序号:(VI)Methyl 4-hydroxybenzoate (I) is iodinated by means of iodine monochloride in hot AcOH, producing (II). Displacement of the aryl iodide (II) with CuCN gives nitrile (III). Then, ester group saponification in (III) leads to 3-cyano-4-hydroxybenzoic acid (IV). Coupling of (IV) with tert-butyl carbazate produces the N-Boc hydrazide (V), which is further deprotected to (VI) by treatment with trifluoroacetic acid
【1】 Ling, A.; Plewe, M.; Gonzalez, J.; et al.; Human glucagon receptor antagonists based on alkylidene hydrazides. Bioorg Med Chem Lett 2002, 12, 4, 663. |
【2】 Gonzales, J.; Sams, C.; Teng, M. (Alanex Corp.; Novo Nordisk A/S); Glucagon antagonists/inverse agonists. EP 0994848; WO 9901423 . |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 10251 | methyl 4-hydroxybenzoate; Methyl p-hydroxybenzoate | 99-76-3 | C8H8O3 | 详情 | 详情 |
(II) | 60844 | methyl 4-hydroxy-3-iodobenzoate | C8H7IO3 | 详情 | 详情 | |
(III) | 60845 | methyl 3-cyano-4-hydroxybenzoate | C9H7NO3 | 详情 | 详情 | |
(IV) | 60846 | 3-cyano-4-hydroxybenzoic acid | C8H5NO3 | 详情 | 详情 | |
(V) | 60847 | tert-butyl 2-(3-cyano-4-hydroxybenzoyl)-1-hydrazinecarboxylate | C13H15N3O4 | 详情 | 详情 | |
(VI) | 60848 | 3-cyano-4-hydroxybenzohydrazide | C8H7N3O2 | 详情 | 详情 |
合成路线3
该中间体在本合成路线中的序号:(VI)Alkylation of 4-hydroxy-3,5-dimethoxybenzaldehyde (VII) with 4-isopropylbenzyl chloride (VIII) affords the benzyloxy benzaldehyde (IX). Then, condensation of aldehyde (IX) with hydrazide (VI) furnishes the target N-acyl hydrazone
【1】 Ling, A.; Plewe, M.; Gonzalez, J.; et al.; Human glucagon receptor antagonists based on alkylidene hydrazides. Bioorg Med Chem Lett 2002, 12, 4, 663. |
【2】 Gonzales, J.; Sams, C.; Teng, M. (Alanex Corp.; Novo Nordisk A/S); Glucagon antagonists/inverse agonists. EP 0994848; WO 9901423 . |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(VI) | 60848 | 3-cyano-4-hydroxybenzohydrazide | C8H7N3O2 | 详情 | 详情 | |
(VII) | 49243 | 3,5-Dimethoxy-4-hydroxybenzaldehyde; 4-Hydroxy-3,5-dimethoxybenzaldehyde; Syringaldehyde | 134-96-3 | C9H10O4 | 详情 | 详情 |
(VIII) | 33769 | 1-(chloromethyl)-4-isopropylbenzene | 2051-18-5 | C10H13Cl | 详情 | 详情 |
(IX) | 60849 | 4-[(4-isopropylbenzyl)oxy]-3,5-dimethoxybenzaldehyde | C19H22O4 | 详情 | 详情 |